Bio-Rad Laboratories (NYSE:BIO.B – Get Free Report) released its quarterly earnings data on Thursday. The company reported $3.11 earnings per share for the quarter, Zacks reports. Bio-Rad Laboratories had a negative net margin of 51.73% and a positive return on equity of 3.56%. The company had revenue of $638.48 million for the quarter.
Bio-Rad Laboratories Stock Performance
BIO.B stock traded up $32.55 during trading hours on Friday, hitting $326.78. 119 shares of the stock were exchanged, compared to its average volume of 26. Bio-Rad Laboratories has a 12 month low of $271.00 and a 12 month high of $373.78. The company has a current ratio of 6.57, a quick ratio of 4.89 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $9.32 billion, a P/E ratio of -31.54 and a beta of 0.72. The company has a 50-day simple moving average of $286.51 and a two-hundred day simple moving average of $305.51.
About Bio-Rad Laboratories
See Also
- Five stocks we like better than Bio-Rad Laboratories
- What is an Earnings Surprise?
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Roth IRA Calculator: Calculate Your Potential Returns
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.